LLY vs MCK
By Alex · Tickerpine
Eli Lilly and Company vs McKesson Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | MCK |
|---|---|---|
| Price | $1,233.66 | $905.09 |
| Market cap | $1.10T | $105.52B |
| P/E ratio | 41.8 | 23.4 |
| ROE | 102.29% | — |
| Profit margin | 33.53% | 1.12% |
| Revenue growth | 47.70% | 7.70% |
| Dividend yield | 0.55% | 0.43% |
| Beta | 0.51 | 0.31 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs MCK in plain English
- LLY is the bigger company — about 10.4× the market cap of MCK.
- MCK is cheaper on earnings (P/E 23.4 vs 41.8).
- LLY is growing revenue faster (48% vs 8%).
- LLY has the higher dividend yield (0.55% vs 0.43%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
MCK return calculator
See what $1,000 in McKesson Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.